HCA Healthcare (HCA) Stock Forecast & Price Target

Compare

1,765 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

10 Buy

5 Hold

1 Sell

Based on 16 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$529.71

▲(8.49% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $529.71 with a high forecast of $598.00 and a low forecast of $420.00. The average price target represents a 8.49% change from the last price of $488.27.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"296":"$296","599":"$599","371.75":"$371.8","447.5":"$447.5","523.25":"$523.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":598,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$598.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":529.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$529.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":420,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$420.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[296,371.75,447.5,523.25,599],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.86,476.9476923076923,487.0353846153846,497.12307692307695,507.21076923076924,517.2984615384615,527.3861538461539,537.4738461538461,547.5615384615385,557.6492307692308,567.7369230769231,577.8246153846154,587.9123076923076,{"y":598,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.86,471.6946153846154,476.52923076923076,481.36384615384617,486.1984615384616,491.0330769230769,495.8676923076923,500.7023076923077,505.53692307692313,510.3715384615385,515.2061538461538,520.0407692307692,524.8753846153846,{"y":529.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.86,463.2553846153846,459.65076923076924,456.04615384615386,452.44153846153847,448.8369230769231,445.2323076923077,441.6276923076923,438.0230769230769,434.41846153846154,430.81384615384616,427.20923076923077,423.6046153846154,{"y":420,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":297.915,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.454,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.019,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.931,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.255,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":380.172,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.256,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.803,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.639,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":425.437,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":458.997,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":502.252,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.86,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$598.00

Average Price Target$529.71

Lowest Price Target$420.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

$452→$481

Hold

-1.49%

Downside

Reiterated

01/30/26

HCA Healthcare price target raised to $481 from $452 at Wells FargoHCA Healthcare price target raised to $481 from $452 at Wells Fargo

David S Macdonald

Truist Financial

$520→$546

Buy

11.82%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Viridian Therapeutics (NASDAQ: VRDN)

Michael Wiederhorn

Oppenheimer

$500→$540

Buy

10.59%

Upside

Reiterated

01/28/26

HCA Healthcare price target raised to $540 from $500 at OppenheimerHCA Healthcare price target raised to $540 from $500 at Oppenheimer

A.J. Rice

UBS

$525→$598

Buy

22.47%

Upside

Reiterated

01/28/26

HCA Healthcare price target raised to $598 from $525 at UBSHCA Healthcare price target raised to $598 from $525 at UBS

Ann Hynes

Mizuho Securities

Buy

―

Reiterated

01/28/26

Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA)

Brian Tanquilut

Jefferies

$535→$590

Buy

20.83%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Danaher (NYSE: DHR)

Craig Hettenbach

Morgan Stanley

$425

Sell

-12.96%

Downside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Andrew Mok CFA

Barclays

$551

Buy

12.85%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)

Matthew Gillmor CFA

KeyBanc

$500→$550

Buy

12.64%

Upside

Reiterated

01/28/26

HCA Healthcare (HCA) Gets a Buy from KeyBanc

Ryan Langston

TD Cowen

$490→$529

Buy

8.34%

Upside

Reiterated

01/28/26

Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$525→$555

Buy

13.67%

Upside

Reiterated

01/27/26

RBC Capital Remains a Buy on HCA Healthcare (HCA)

Sarah James

Cantor Fitzgerald

$525→$588

Buy

20.43%

Upside

Reiterated

01/27/26

Analysts Conflicted on These Healthcare Names: Becton Dickinson (NYSE: BDX), Ocular Therapeutix (NASDAQ: OCUL) and HCA Healthcare (NYSE: HCA)

Joanna Gajuk

Bank of America Securities

$485→$540

Hold

10.59%

Upside

Reiterated

01/27/26

HCA Healthcare price target raised to $540 from $485 at BofAHCA Healthcare price target raised to $540 from $485 at BofA

Lance Wilkes

Bernstein

$503

Hold

3.02%

Upside

Reiterated

01/27/26

HCA Healthcare (HCA) Receives a Hold from Bernstein

Jason Cassorla

Guggenheim

Hold

―

Reiterated

01/27/26

Guggenheim Sticks to Their Hold Rating for HCA Healthcare (HCA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

$452→$481

Hold

-1.49%

Downside

Reiterated

01/30/26

HCA Healthcare price target raised to $481 from $452 at Wells FargoHCA Healthcare price target raised to $481 from $452 at Wells Fargo

David S Macdonald

Truist Financial

$520→$546

Buy

11.82%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Viridian Therapeutics (NASDAQ: VRDN)

Michael Wiederhorn

Oppenheimer

$500→$540

Buy

10.59%

Upside

Reiterated

01/28/26

HCA Healthcare price target raised to $540 from $500 at OppenheimerHCA Healthcare price target raised to $540 from $500 at Oppenheimer

A.J. Rice

UBS

$525→$598

Buy

22.47%

Upside

Reiterated

01/28/26

HCA Healthcare price target raised to $598 from $525 at UBSHCA Healthcare price target raised to $598 from $525 at UBS

Ann Hynes

Mizuho Securities

Buy

―

Reiterated

01/28/26

Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA)

Brian Tanquilut

Jefferies

$535→$590

Buy

20.83%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Danaher (NYSE: DHR)

Craig Hettenbach

Morgan Stanley

$425

Sell

-12.96%

Downside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Andrew Mok CFA

Barclays

$551

Buy

12.85%

Upside

Reiterated

01/28/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)

Matthew Gillmor CFA

KeyBanc

$500→$550

Buy

12.64%

Upside

Reiterated

01/28/26

HCA Healthcare (HCA) Gets a Buy from KeyBanc

Ryan Langston

TD Cowen

$490→$529

Buy

8.34%

Upside

Reiterated

01/28/26

Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$525→$555

Buy

13.67%

Upside

Reiterated

01/27/26

RBC Capital Remains a Buy on HCA Healthcare (HCA)

Sarah James

Cantor Fitzgerald

$525→$588

Buy

20.43%

Upside

Reiterated

01/27/26

Analysts Conflicted on These Healthcare Names: Becton Dickinson (NYSE: BDX), Ocular Therapeutix (NASDAQ: OCUL) and HCA Healthcare (NYSE: HCA)

Joanna Gajuk

Bank of America Securities

$485→$540

Hold

10.59%

Upside

Reiterated

01/27/26

HCA Healthcare price target raised to $540 from $485 at BofAHCA Healthcare price target raised to $540 from $485 at BofA

Lance Wilkes

Bernstein

$503

Hold

3.02%

Upside

Reiterated

01/27/26

HCA Healthcare (HCA) Receives a Hold from Bernstein

Jason Cassorla

Guggenheim

Hold

―

Reiterated

01/27/26

Guggenheim Sticks to Their Hold Rating for HCA Healthcare (HCA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months

xxx

Success Rate

14/17 ratings generated profit

Average Return

+9.58%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 82.35% of your transactions generating a profit, with an average return of +9.58% per trade.

1 Year

Andrew Mok CFABarclays

Success Rate

17/17 ratings generated profit

Average Return

+28.84%

reiterated a buy rating 4 days ago

Copying Andrew Mok CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +28.84% per trade.

2 Years

xxx

Success Rate

46/46 ratings generated profit

Average Return

+55.25%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +55.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 30 Buy Ratings, 20 Hold Ratings, and 2 Sell Ratings. HCA average Analyst price target in the past 3 months is 529.71.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $7.17 with a range of $6.72 to $7.65. The previous quarter’s EPS was $8.01. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $19.09B with a range of $18.63B to $19.23B. The previous quarter’s sales results were $19.51B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, Hca Healthcare’s 12-month average price target is 529.71.

What is HCA’s upside potential, based on the analysts’ average price target?

Hca Healthcare has 8.49% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

Hca Healthcare has a consensus rating of Moderate Buy which is based on 10 buy ratings, 5 hold ratings and 1 sell ratings.

What is Hca Healthcare’s price target?

The average price target for Hca Healthcare is 529.71. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $598.00 ,the lowest forecast is $420.00. The average price target represents 8.49% Increase from the current price of $488.27.

What do analysts say about Hca Healthcare?

Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Detailed List of Analyst Forecasts